Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,54 USD | -1,59% | -0,09% | -25,72% |
18/03 | AMICUS THERAPEUTICS, INC. : JPMorgan Chase nog altijd een koopadvies | ZM |
05/03 | Insider van Amicus Therapeutics verkocht aandelen ter waarde van $389.543, volgens een recent SEC-document | MT |
Vakgebied
Aantal werknemers: 517
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Advanced Therapies
100,0
%
| 329 | 100,0 % | 399 | 100,0 % | +21,30% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Non-United States
63,2
%
| 213 | 64,8 % | 252 | 63,2 % | +18,35% |
United States
36,8
%
| 116 | 35,2 % | 147 | 36,8 % | +26,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 01-04-06 |
Simon Harford
DFI | Director of Finance/CFO | 64 | 21-08-23 |
Pat O’Sullivan
COO | Chief Operating Officer | - | 01-07-22 |
Mitchell Goldman
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Jill Weimer
CTO | Chief Tech/Sci/R&D Officer | - | 13-06-19 |
Patrik Florencio
CMP | Compliance Officer | - | 01-08-15 |
Andrew Faughnan
IRC | Investor Relations Contact | - | - |
Stephen Arnold
PRN | Corporate Officer/Principal | - | 01/11 |
David Clark
HRO | Human Resources Officer | 49 | 01-10-18 |
Samantha Prout
AUD | Comptroller/Controller/Auditor | 46 | 01-03-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 01-04-06 |
Lynn Bleil
BRD | Director/Board Member | 60 | 11-09-18 |
Burke W. Whitman
BRD | Director/Board Member | 68 | 27-06-19 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 01-10-09 |
Michael Kelly
BRD | Director/Board Member | 67 | 01-12-20 |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 01-06-06 |
Craig Wheeler
BRD | Director/Board Member | 63 | 10-06-16 |
Mike Raab Raab
CHM | Chairman | 59 | 01-01-04 |
Eiry Roberts
BRD | Director/Board Member | 60 | 10-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 295 382 614 | 265 100 314 ( 89,75 %) | 0 | 89,75 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,72% | 3,11 mld. | |
+4,09% | 43,84 mld. | |
+47,81% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |
- Beurs
- Aandelen
- Koers FOLD
- Onderneming Amicus Therapeutics, Inc.